Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFIBROTIDE for Covid-19: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where DEFIBROTIDE was used for Covid-19.

Most Reported Side Effects for DEFIBROTIDE

Side Effect Reports % Deaths Hosp.
Off label use 1,323 35.4% 375 180
Venoocclusive disease 576 15.4% 125 79
Death 463 12.4% 463 148
Multiple organ dysfunction syndrome 372 10.0% 337 125
Venoocclusive liver disease 355 9.5% 272 73
Intentional product use issue 201 5.4% 39 31
Hypotension 169 4.5% 134 72
Haemorrhage 156 4.2% 60 35
Sepsis 143 3.8% 110 56
Acute graft versus host disease 140 3.7% 69 56
Gastrointestinal haemorrhage 125 3.3% 71 48
Septic shock 113 3.0% 107 61
Renal failure 111 3.0% 68 47
Drug ineffective 106 2.8% 72 27
Disease progression 100 2.7% 78 16

Other Indications for DEFIBROTIDE

Venoocclusive disease (1,325) Venoocclusive liver disease (1,228) Prophylaxis (1,073) Product used for unknown indication (375) Thrombotic microangiopathy (34) Pulmonary veno-occlusive disease (8) Hepatic failure (7) Off label use (7) Thrombosis (7) Microangiopathy (6)

Other Drugs Used for Covid-19

REMDESIVIR (7,196) HYDROXYCHLOROQUINE (5,280) BAMLANIVIMAB (4,621) NIRMATRELVIR\RITONAVIR (4,587) TOCILIZUMAB (4,186) DEXAMETHASONE (2,975) CASIRIVIMAB\IMDEVIMAB (2,943) SOTROVIMAB (2,732) AZITHROMYCIN ANHYDROUS (2,510) METHYLPREDNISOLONE (1,633)

Related Pages

DEFIBROTIDE Full Profile All Covid-19 Drugs DEFIBROTIDE Demographics DEFIBROTIDE Timeline